HIGHLIGHTS
- who: Yongmei Zhao from the School of Pharmacy, Nantong University, Nantong, China NICM Health Research Institute, Western Sydney University, Westmead, NSW, Australia , have published the paper: Docetaxel-loaded M1 macrophage-derived exosomes for a safe and efficient chemoimmunotherapy of breast cancer, in the Journal: (JOURNAL)
- what: For the first time, the authors report chemotherapy-enabled macrophage programming strategy via modulating mitochondrial functions, aiming to achieve highly effective immunotherapy.
- how: Data were analyzed using the IncuCyte software. The results showed that DTX-M1-Exo prolonged M1 macrophage polarization even upon M2 macrophage stimulation. In . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.